235 related articles for article (PubMed ID: 21429186)
1. Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites.
Kraus B; Boller K; Reuter A; Schnierle BS
Retrovirology; 2011 Mar; 8():21. PubMed ID: 21429186
[TBL] [Abstract][Full Text] [Related]
2. Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element.
George M; Schwecke T; Beimforde N; Hohn O; Chudak C; Zimmermann A; Kurth R; Naumann D; Bannert N
Retrovirology; 2011 May; 8():30. PubMed ID: 21554716
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution in a segment of the CA protein within Gag that has similarity to human immunodeficiency virus type 1 blocks infectivity of a human endogenous retrovirus K provirus in the human genome.
Heslin DJ; Murcia P; Arnaud F; Van Doorslaer K; Palmarini M; Lenz J
J Virol; 2009 Jan; 83(2):1105-14. PubMed ID: 19004950
[TBL] [Abstract][Full Text] [Related]
4. Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1.
Monde K; Contreras-Galindo R; Kaplan MH; Markovitz DM; Ono A
J Virol; 2012 Oct; 86(20):11194-208. PubMed ID: 22855497
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity.
Monde K; Terasawa H; Nakano Y; Soheilian F; Nagashima K; Maeda Y; Ono A
Retrovirology; 2017 Apr; 14(1):27. PubMed ID: 28446240
[TBL] [Abstract][Full Text] [Related]
6. Analysis of human immunodeficiency virus type 1 containing HERV-K protease.
Padow M; Lai L; Fisher RJ; Zhou YC; Wu X; Kappes JC; Towler EM
AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1973-80. PubMed ID: 11153080
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic processing and assembly of gag and gag-pol proteins of TED, a baculovirus-associated retrotransposon of the gypsy family.
Hajek KL; Friesen PD
J Virol; 1998 Nov; 72(11):8718-24. PubMed ID: 9765414
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human endogenous retrovirus type K virus-like particles generated from recombinant baculoviruses.
Tönjes RR; Boller K; Limbach C; Lugert R; Kurth R
Virology; 1997 Jul; 233(2):280-91. PubMed ID: 9217052
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human endogenous retrovirus-K10 protease in cell-free and cell-based assays.
Kuhelj R; Rizzo CJ; Chang CH; Jadhav PK; Towler EM; Korant BD
J Biol Chem; 2001 May; 276(20):16674-82. PubMed ID: 11278433
[TBL] [Abstract][Full Text] [Related]
10. Reconstitution of an infectious human endogenous retrovirus.
Lee YN; Bieniasz PD
PLoS Pathog; 2007 Jan; 3(1):e10. PubMed ID: 17257061
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease?
Towler EM; Gulnik SV; Bhat TN; Xie D; Gustschina E; Sumpter TR; Robertson N; Jones C; Sauter M; Mueller-Lantzsch N; Debouck C; Erickson JW
Biochemistry; 1998 Dec; 37(49):17137-44. PubMed ID: 9860826
[TBL] [Abstract][Full Text] [Related]
12. Properties of avian retrovirus particles defective in viral protease.
Stewart L; Schatz G; Vogt VM
J Virol; 1990 Oct; 64(10):5076-92. PubMed ID: 1697912
[TBL] [Abstract][Full Text] [Related]
13. Human endogenous retrovirus family HERV-K(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line Tera-1 and originate mainly from a provirus on chromosome 22q11.21.
Ruprecht K; Ferreira H; Flockerzi A; Wahl S; Sauter M; Mayer J; Mueller-Lantzsch N
J Virol; 2008 Oct; 82(20):10008-16. PubMed ID: 18684837
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines.
Bieda K; Hoffmann A; Boller K
J Gen Virol; 2001 Mar; 82(Pt 3):591-596. PubMed ID: 11172100
[TBL] [Abstract][Full Text] [Related]
15. Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing.
Chiu HC; Wang FD; Chen YA; Wang CT
J Gen Virol; 2006 Jul; 87(Pt 7):2041-2046. PubMed ID: 16760407
[TBL] [Abstract][Full Text] [Related]
16. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
[TBL] [Abstract][Full Text] [Related]
17. The transmembrane protein of the human endogenous retrovirus--K (HERV-K) modulates cytokine release and gene expression.
Morozov VA; Dao Thi VL; Denner J
PLoS One; 2013; 8(8):e70399. PubMed ID: 23950929
[TBL] [Abstract][Full Text] [Related]
18. Sequence variability, gene structure, and expression of full-length human endogenous retrovirus H.
Jern P; Sperber GO; Ahlsén G; Blomberg J
J Virol; 2005 May; 79(10):6325-37. PubMed ID: 15858016
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.
Shehu-Xhilaga M; Crowe SM; Mak J
J Virol; 2001 Feb; 75(4):1834-41. PubMed ID: 11160682
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.
Tönjes RR; Czauderna F; Kurth R
J Virol; 1999 Nov; 73(11):9187-95. PubMed ID: 10516026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
